Cancer BiologyTherapeutic Advances in Medical OncologyPeer-reviewed
Enhancing efficacy of the MEK inhibitor trametinib with paclitaxel in KRAS-mutated colorectal cancer
Susmita Ghosh, Fan Fan, Reid Trenton Powell…·Rajat Bhattacharya
This study identifies paclitaxel as a synergistic partner for trametinib in KRAS-mutated colorectal cancer, showing enhanced anti-tumor effects in vitro and in vivo.
4 citations